Plasma membrane Ca2+ pumping plays a prominent role in adenosine A1 receptor mediated changes in [Ca2+](i) in DDT1 MF-2 cells

European Journal of Pharmacology

Volumn 306, Issue 1-3, 1996, Pages 187-194

  Sipma, Henk ^a   Fredholm, Bertil B ^b   Den Hertog, Adriaan ^a   Nelemans, Adriaan ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

adenosine A1 receptor; Ca2+; Ca2+ pumping; DDT1; MF 2 cell; temperature

Indexed keywords

6 N CYCLOPENTYLADENOSINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE INHIBITOR; CALCIUM; CALCIUM 45; INOSITOL 1,4,5 TRISPHOSPHATE; LANTHANUM CHLORIDE; ORTHOVANADIC ACID; PHOSPHOLIPASE C; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; PROTEIN TYROSINE PHOSPHATASE; THAPSIGARGIN; TYRPHOSTIN 25; UNCLASSIFIED DRUG; ADENOSINE RECEPTOR; DRUG DERIVATIVE; VANADIC ACID;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL MEMBRANE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVITY; ION EXCHANGE; MEMBRANE TRANSPORT; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; TEMPERATURE; ANIMAL; BIOSYNTHESIS; CELL LINE; DRUG EFFECT; GENETICS; HAMSTER; MALE; METABOLISM; PHYSIOLOGY; SMOOTH MUSCLE; SYRIAN HAMSTER; VAS DEFERENS;

ADENOSINE; ANIMALS; CALCIUM; CALCIUM-TRANSPORTING ATPASES; CELL LINE; CELL MEMBRANE; CRICETINAE; INOSITOL 1,4,5-TRISPHOSPHATE; MALE; MESOCRICETUS; MUSCLE, SMOOTH; PHOSPHOLIPASE C; RECEPTORS, PURINERGIC P1; TEMPERATURE; VANADATES; VAS DEFERENS;

EID: 0030582081     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00183-5     Document Type: Article

References (41)

1. 2+ stores, Biochem. J. 280, 783.
2. Atkinson, T.P., C-W. Lee, S.G. Rhee and J. Hohman, 1993, Orthovanadate induces translocation of phospholipase C-γ1 and -γ2 in permeabilized mast cells, J. Immunol. 151, 1448.
3. 2+ pump of the plasma membrane, J. Biol. Chem. 267, 2115.
4. Champeil, P., L. Combattes, B. Berthon, E. Doucet, S. Orlowski and M. Claret, 1989, Fast kinetics of calcium release induced by myo-inositol trisphosphate in permeabilized rat hepatocytes, J. Biol. Chem. 264, 17665.
5. Chilvers, E.R., R.A.J. Challis, P.J. Barnes and S.R. Nahorski, 1989, Mass changes in inositol 1,4,5-trisphosphate in trachealis muscle following agonist stimulation, Eur. J. Pharmacol. 164, 587.
6. Den Hertog, A, 1981, Calcium and a-action of catecholamines of guinea-pig taenia caeci, J. Physiol. 316, 109.
7. Den Hertog, A., 1992, Calcium release from separate receptor-specific intracellular stores induced by histamine and ATP in a hamster cell line, J. Physiol. 454, 591.
8. 1 MF-2, Br. J. Pharmacol. 108, 85.
9. 2+ efflux from hepatocytes, J. Biol. Chem. 264, 20863.
10. Fredholm, B.B., M.P. Abbracchio, G. Burnstock, J.W. Daly, T.K. Harden, K.A. Jacobson, P. Leff and M. Williams, 1994, International Union of Pharmacology Nomenclature: classification of purinoceptors, Pharmacol. Rev. 46, 143.
11. 1 MF-2 smooth muscle cells, Mol. Pharmacol. 40, 149.
12. Gerwins, P. and B.B. Fredholm, 1992a, ATP and its metabolite adenosine act synergistically to mobilize intracellular calcium via the formation of inositol 1,4,5-trisphosphate in a smooth muscle cell line, J. Biol. Chem. 267, 16081.
13. 1 MF-2 smooth muscle cells, Proc. Natl. Acad. Sci. 89, 7330.
14. 1 MF-2 smooth muscle cells, Mol. Pharmacol. 38, 660.
15. Grinstein, S., W. Furuya, D.J. Lu and G.B. Mills, 1990, Vanadate stimulates oxygen consumption and tyrosine phosphorylation in electropermeabilized human neutrophils, J. Biol. Chem. 265, 318.
16. 2+ indicators with greatly improved fluorescence properties, J. Biol. Chem. 260, 3440.
17. 2 and vanadate stimulate protein tyrosine phosphorylation in intact cells, J. Biol. Chem. 265, 2896.
18. Hesketh, T.R., G.A. Smith, J.P. Moore, M.V. Taylor and J.C. Metcalfe, 1983, Free cytoplasmic calcium concentration and mitogenic stimulation of lymphocytes, J. Biol. Chem. 258, 4876.
19. 1 MF-2 smooth muscle cells, Eur J. Pharmacol. 189, 31.
20. Klarlund, J.K, 1985, Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteins. Cell 41, 707.
21. 2+ transients are not required for platelet-derived growth factor to induce cell cycle progression of vascular smooth muscle cells in primary culture, J. Biol. Chem. 269, 9011.
22. 2+ entry by tyrosine kinase inhibitors, J. Biol. Chem. 268, 9945.
23. Lytton, J., M. Westlin and M.R. Hanley. 1991, Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps, J. Biol. Chem. 266, 17067.
24. 1 MF-2 cells, J. Biol. Chem. 266, 5658.
25. 2+-mobilizing receptor, J. Biol. Chem. 269, 30854.
26. 2+)-ATPase of the erythrocyte membrane, J. Biol. Chem. 256, 395.
27. Norris, J.S., J. Gorski and P.O. Kohler, 1974, Androgen receptors in a syrian hamster ductus deferens tumour cell line, Nature, 248, 422.
28. 3 production and amylase release in pancreatic acini, Am. J. Physiol. 266, G363.
29. 2+ entry, Cell Calcium 7, 1.
30. 1 MF-2 smooth muscle cells, Mol. Pharmacol. 37, 149.
31. 3-sensitive channels that are sensed by neighbouring mitochondria, Science 262, 744.
32. Rojas, E., P.B. Carroll, C. Ricordi, A.C. Boschero, S.S. Stojilkovic and I. Atwater, 1994, control of cytosolic free calcium in cultured human pancreatic β-cells occurs by external calcium-dependent and independent mechanisms, Endocrinology 134, 1771.
33. 1-MF-2 smooth muscle cell line, Mol. Pharmacol. 41, 587.
34. Schachter, J.B., J.K. Ivins, R.N. Pittman and B.B. Wolfe, 1992, Competitive regulation of phospholipase C responses by cAMP and calcium, Mol. Pharmacol. 41, 577.
35. 2+ within organelles, J. Biol. Chem. 268, 25887.
36. 2-adenosine receptor agonists do not alter potential duration, twitch shortening, or cAMP accumulation in guinea pig, rat, or rabbit isolated ventricular myocytes, Circulation Res. 72, 194.
37. 1 MF-2 cells, Br. J. Pharmacol. 114, 383.
38. 2+-ATPase, Proc. Natl. Acad. Sci. USA 87, 2466.
39. 1 MF-2 cells, Eur. J. Pharmacol. Mol. Pharmacol. Sect. 289, 463.
40. 2+ stores, Cell Biol. Int. 18 (5), 301.
41. 1 MF-2 cells, Br. J. Pharmacol. 106, 215.